AYTU BIOPHARMA, INC (AYTU) Operating income 2016–2025
AYTU BIOPHARMA, INC (AYTU) annual operating income history from SEC filings — each fiscal year as reported.
-$7.8MFY2025 · since FY2016: -$21.7M → -$7.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$7.8M | -392.0% |
| FY2024 | -$1.6M | +90.7% |
| FY2023 | -$17.1M | +84.5% |
| FY2022 | -$109.9M | -86.7% |
| FY2021 | -$58.9M | -178.6% |
| FY2020 | -$21.1M | -25.4% |
| FY2019 | -$16.8M | +14.5% |
| FY2018 | -$19.7M | +2.1% |
| FY2017 | -$20.1M | +7.3% |
| FY2016 | -$21.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice